![]() |
市場調査レポート
商品コード
1623747
実践療法の市場規模、シェア、成長分析、療法タイプ別、提供方法別、用途別、地域別-産業予測、2025~2032年Practice Therapy Market Size, Share, Growth Analysis, By Therapy Type (Physical Therapy, Occupational Therapy), By Delivery Mode (In-Person Therapy, Teletherapy/Online Therapy), By Application, By Region - Industry Forecast 2025-2032 |
||||||
|
実践療法の市場規模、シェア、成長分析、療法タイプ別、提供方法別、用途別、地域別-産業予測、2025~2032年 |
出版日: 2024年12月25日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3~5営業日
|
実践療法の世界市場規模は、2023年に5,658億4,000万米ドルと評価され、2024年の6,427億9,000万米ドルから2032年には1兆7,827億8,000万米ドルに成長し、予測期間(2025~2032年)のCAGRは13.6%で成長する展望です。
実践療法市場は、特に脳や脊髄のような感受性の高い部位のがん罹患率が世界的に上昇していることが大きな成長の原動力となっています。この治療法は、健康な組織を保護しながら腫瘍に高線量の放射線を照射できることが、採用増加の主要要因となっています。小型陽子線治療システムやMRIガイド下陽子線治療などの技術革新により、その利用しやすさと精度はさらに向上しています。しかし、治療センター設立に必要な高額な初期投資や、保険適用を決定するためのより多くの裏付けとなるエビデンスを必要とする進化する保険償還の状況など、課題も残っています。さらに、実践療法の施設は先進国に集中しているため、患者のアクセスに格差が生じており、公平な治療が受けられるようにするためには、このセグメントの拡大とトレーニングの強化が必要であることが浮き彫りになっています。
Global Practice Therapy Market size was valued at USD 565.84 billion in 2023 and is poised to grow from USD 642.79 billion in 2024 to USD 1782.78 billion by 2032, growing at a CAGR of 13.6% during the forecast period (2025-2032).
The practice therapy market is witnessing significant growth driven by the rising global incidence of cancer, particularly in sensitive areas like the brain and spinal cord. This treatment modality's ability to deliver high doses of radiation to tumors while protecting healthy tissues is a key factor behind its increasing adoption. Technological innovations, such as compact proton therapy systems and MRI-guided proton therapy, have further enhanced its accessibility and precision. However, challenges remain, including the high initial investment required for establishing therapy centers and the evolving reimbursement landscape that needs more supportive evidence for coverage decisions. Additionally, the concentration of practice therapy facilities in developed nations creates disparities in patient access, highlighting the need for expansion and increased training in this field to ensure equitable treatment availability.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Practice Therapy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Practice Therapy Market Segmental Analysis
Global Practice Therapy Market is segmented by therapy type, delivery mode, application, end-user and region. Based on therapy type, the market is segmented into physical therapy, occupational therapy, speech therapy, psychotherapy, rehabilitation therapy and complementary and alternative therapies. Based on delivery mode, the market is segmented into in-person therapy, teletherapy/online therapy and hybrid therapy (combination of in-person and online). Based on application, the market is segmented into pain management, mental health disorders, post-surgery recovery, injury rehabilitation, chronic disease management and developmental disorders. Based on end-user, the market is segmented into individual patients, hospitals and clinics, rehabilitation centers, home care settings and corporate wellness programs. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Practice Therapy Market
One of the key drivers propelling the global practice therapy market is the escalating prevalence of cancer worldwide. As cancer rates continue to rise, there is an increasing demand for effective treatment options, and practice therapy is gaining recognition for its ability to provide targeted and precise solutions for different tumor types. This growing awareness among patients and healthcare providers is leading to a heightened interest in practice therapy as a viable alternative, ultimately fueling market growth. The need for innovative therapies to combat the complex challenges of cancer is creating significant opportunities within this sector.
Restraints in the Global Practice Therapy Market
The Practice Therapy market faces several restraints, notably related to reimbursement challenges. The reimbursement framework is continuously changing and differs significantly across regions. The absence of standardized policies along with the demand for additional evidence and cost-effectiveness studies can influence payers' reimbursement choices. These factors create obstacles that may hinder the broader acceptance and implementation of Practice Therapy solutions. As stakeholders seek to navigate these complexities, the variability in reimbursement practices presents a significant challenge that could limit the growth and accessibility of Practice Therapy in various markets worldwide.
Market Trends of the Global Practice Therapy Market
The Global Practice Therapy market is witnessing a significant trend towards the increasing adoption of hypofractionation, a methodology characterized by delivering higher radiation doses per session to shorten overall treatment duration. This approach is rapidly gaining traction as clinical studies indicate that hypofractionation is not only as effective as conventional fractionation but also enhances patient convenience by reducing the number of treatment sessions required. This shift is likely to drive market growth through improved patient outcomes, greater operational efficiency, and a focus on personalized care. As healthcare systems evolve, the demand for innovative treatment strategies will further escalate, solidifying hypofractionation's position in therapeutic practices.